Fundació ACE   Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: Barcelona Spain (1995)

Organization Overview

First Clinical Trial
1995
NCT01408836
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Fundació ACE. Barcelona Alzheimer Treatment and Research Center | Fundació ACE. Barcelona. Spain | Fundació ACE Institut Català de Neurociències Aplicades | Fundació Centre de Recerca en Epidemiologia Ambiental, Barcelona, Spain | Fundacio Clinic | Fundacio Clinic Barcelona

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 3)

Amyloidosis (Phase 2)

Breast Neoplasms (Phase 2)

Granulomatosis with Polyangiitis (Phase 3)

Malaria (Phase 2)

Malaria, Falciparum (Phase 2)

Microscopic Polyangiitis (Phase 3)

Obesity (Phase 2)

Vasculitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 14